Thrombocytopenia is a common haematological disorder in patients with chronic liver
disease. It is multifactorial and severity of liver disease is the most influential factor. As a …

Gastroesophageal varices are present at diagnosis in almost half of patients with cirrhosis,
and variceal hemorrhage continues to be a lethal complication of cirrhosis. This review …

Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …

In patients with compensated advanced chronic liver disease (cACLD), the presence of
clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears …

Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …

BACKGROUND & AIMS: Noninvasive methods are needed to identify clinically significant
portal hypertension (CSPH) and esophageal varices (EVs) in patients with compensated …

BACKGROUND & AIMS: The hepatic vein pressure gradient (HVPG) is the standard used to
determine the degree of portal hypertension (PH) and an important prognostic factor for …

Portal hypertension is a common complication of chronic liver diseases and is responsible
for most clinical consequences of cirrhosis, which represent the more frequent causes of …

Chronic infection with hepatitis C virus (HCV) is a leading cause of liver-related morbidity
and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications …